Merck & Co. Inc. buy Guggenheim
Start price
12.02.25
/
50%
€83.40
Target price
12.02.26
€110.77
Performance (%)
5.53%
Price
24.11.25
€87.20
Summary
This prediction is currently active. With a performance of 5.53%, the BUY prediction by Guggenheim for Merck & Co. Inc. is trending in the right direction. A total of €0.81 was paid as dividends for this prediction. This prediction currently runs until 12.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 8.728% | 8.728% |
| iShares Core DAX® | -0.906% | -3.980% |
| iShares Nasdaq 100 | 0.913% | -0.897% |
| iShares Nikkei 225® | -1.339% | -2.677% |
| iShares S&P 500 | 1.018% | -0.338% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
26.93%
24.11.25
24.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24

